LZK Polyclonal Antibody

Rabbit Anti-LZK Polyclonal Antibody

Product Specifications

Background

Mitogen-activated protein kinase kinase kinase 13 encoded by MAP3K13 is a member of serine/threonine protein kinase family. Mitogen-activated protein kinase kinase kinase 13 contains a dual leucine-zipper motif, and has been shown to form dimers/oligomers through its leucine-zipper motif. Mitogen-activated protein kinase kinase kinase 13 can phosphorylate and activate MAPK8/JNK, MAP2K7/MKK7, which suggests a role in the JNK signaling pathway.

CAS Number

9007-83-4

Product Name Alternative

MAP3K13; LZK; Mitogen-activated protein kinase kinase kinase 13; Leucine zipper-bearing kinase; Mixed lineage kinase; MLK

Gene ID

9175

Accession Number

O43283

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the Internal region of human LZK at AA range: 120-200

Clonality

Polyclonal

Tag

Mitogen-activated protein kinase kinase kinase 13

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

108kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

LZK Polyclonal Antibody detects endogenous levels of LZK protein.

Observed Molecular Weight

108

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200